Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.

2006 | JOURNAL DOI: 10.1158/0008-5472.CAN-05-4620

1-min quiz | Figure out your research career

See how Impactio can help you with your research career.

Start